Sumitomo Pharma Co Ltd
TSE:4506
Sumitomo Pharma Co Ltd
Cash from Investing Activities
Sumitomo Pharma Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sumitomo Pharma Co Ltd
TSE:4506
|
Cash from Investing Activities
¥69.1B
|
CAGR 3-Years
109%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Investing Activities
-¥840.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
-21%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Investing Activities
-¥201.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-45%
|
CAGR 10-Years
-7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Investing Activities
-¥190.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-16%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Investing Activities
-¥37.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-11%
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Investing Activities
-¥846.4B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-72%
|
CAGR 10-Years
-31%
|
See Also
What is Sumitomo Pharma Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
69.1B
JPY
Based on the financial report for Dec 31, 2023, Sumitomo Pharma Co Ltd's Cash from Investing Activities amounts to 69.1B JPY.
What is Sumitomo Pharma Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
109%
The average annual Cash from Investing Activities growth rates for Sumitomo Pharma Co Ltd have been 109% over the past three years .